Single-cell RNA-seq reveals the genesis and heterogeneity of tumor microenvironment in pancreatic undifferentiated carcinoma with osteoclast-like giant-cells

Abstract

Background Undifferentiated carcinoma with osteoclast-like giant cells (OGCs) of pancreas (UCOGCP) is a rare subtype of pancreatic ductal adenocarcinoma (PDAC), which had poorly described histopathological and clinical features. Methods In this study, single-cell RNA sequencing (scRNA-seq) was used to profile the distinct tumor microenvironment of UCOGCP using samples obtained from one UCOGCP patient and three PDAC patients. Bioinformatic analysis was carried out and immunohistochemical (IHC) staining was used to support the findings of bioinformatic analysis. After quality control of the raw data, a total of 18,376 cells were obtained from these four samples for subsequent analysis. These cells were divided into ten main cell types following the Seurat analysis pipeline. Among them, the UCOGCP sample displayed distinct distribution patterns from the rest samples in the epithelial cell, myeloid cell, fibroblast, and endothelial cell clusters. Further analysis supported that the OGCs were generated from stem-cell-like mesenchymal epithelial cells (SMECs). Results Functional analysis showed that the OGCs cluster was enriched in antigen presentation, immune response, and stem cell differentiation. Gene markers such as LOX, SPERINE1, CD44, and TGFBI were highly expressed in this SMECs cluster which signified poor prognosis. Interestingly, in myeloid cell, fibroblasts, and endothelial cell clusters, UCOGCP contained higher percentage of these cells and unique subclusters, compared with the rest of PDAC samples. Conclusions Analysis of cell communication depicted that CD74 plays important roles in the formation of the microenvironment of UCOGCP. Our findings illustrated the genesis and function of OGCs, and the tumor microenvironment (TME) of UCOGCP, providing insights for prognosis and treatment strategy for this rare type of pancreatic cancer.

Integration of single-cell and bulk RNA-seq to establish a predictive signature based on the differentiation trajectory of M2 macrophages in lung adenocarcinoma

“…R package ‘monocle2’ was used for differentiation trajectory and pseudotime analysis of M2 macrophages ( Zhou et al, 2022 ). Subsequently, the ‘BEAM’ (branched expression analysis modeling) statistical algorithm was used to identify heterogeneous genes that play a key role in the differentiation of M2 macrophages ( Wang et al, 2022 ). R package ‘GSVA’ and ‘scMetabolism’ determined the enrichment of signaling pathways at the single-cell level ( Hanzelmann et al, 2013 ; Wu et al, 2022 ).…”

Single-cell RNA sequencing highlights the functional role of human endogenous retroviruses in gallbladder cancer

“…Single-cell RNA sequencing (scRNA-seq) has been widely applied to dissect the cellular composition of tissues and explore functional heterogeneity. 21 , 22 , 23 It provides a convenient way to investigate how HERV expression varies among different cell types. Given that HERVs are dispersed in multiple copies throughout human genome, achieving accurate estimation of locus-specific expression of HERVs with scRNA-seq data is challenging.…”

Clinical value of M1 macrophage-related genes identification in bladder urothelial carcinoma and in vitro validation

“…BLCA is one of the most common and most aggressive malignancies, the worried is that little progress has been made in the treatment of BLCA in the last few decades (Kimura et al, 2020;Lv et al, 2020). It is worth noticing that immunotherapy has shown great potential to treat MIBC and metastatic bladder cancer in the clinic (Nair et al, 2020;Pfail et al, 2021;Zhang et al, 2022). Previous studies have found that macrophages exert different effects on immunotherapeutic responses in advanced cancers (Petty and Yang, 2017;DeNardo and Ruffell, 2019;Zeng et al, 2020;Leblond et al, 2021).…”

“…Tumor microenvironment (TME) is constructed by interacting closely with the extracellular matrix (ECM) and stromal cells to evade detection and eradication by host immune surveillance ( Ge and Ding, 2020 ). Mounting studies have indicated the composition of the TME correlates strongly with immune response and chemotherapy, and regulations in various immune cells from the TME effect the clinical outcome of malignancies ( Erbani et al, 2022 ; Friedrich et al, 2022 ; Pang et al, 2022 ; Wang et al, 2022 ). Tumor-associated macrophages (TAM) drive tumor progression, metastasis, and therapeutic resistance ( Larroquette et al, 2022 )but heterogeneity is a considerable factor in macrophages ( Wu et al, 2020 ).…”